Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Aegerion Pharmaceuticals Inc (NASDAQ:AEGR)

1.49
Delayed Data
As of 4:14pm ET
 -0.02 / -1.32%
Today’s Change
1.23
Today|||52-Week Range
20.45
-85.25%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2012

2013

2014

2015
Revenue and IncomeNet Revenues0.0048.5M158.4M239.9M
 
 
 
 
Cost of Goods Sold0.004.6M13.2M30.3M
 
 
 
 
Depreciation And Amortization197.0K469.0K1.2M22.0M
 
 
 
 
 
 
Operating ExpensesGross Income-197.0K43.5M144.0M187.6M
 
 
 
 
 
General Expenses59.0M105.9M170.7M228.8M
 
 
 
 
 
Research And Development25.2M29.8M38.0M44.9M
 
 
 
 
 
Total Operating Expenses59.2M110.9M185.1M281.2M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-59.2M-62.3M-26.7M-41.3M
 
 
 
 
 
Extraordinary Charge-1.4M-4.0K-5.0K-3.9M
 
 
 
 
 
Interest Expense On Debt937.0K722.0K9.9M27.6M
 
 
 
 
 
Other Expenses-883.0K-211.0K-2.1M1.2M
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-62.3M-63.0M-38.5M-71.6M
 
 
 
 
 
Income Taxes0.00-347.0K-899.0K-1.8M
 
 
 
 
Net Income-62.3M-63.4M-39.4M-73.3M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS23.6M28.9M29.1M28.7M
 
 
 
 
 
Shares To Calculate EPS Diluted23.6M28.9M29.1M28.7M
 
 
 
 
 
 
Earnings Per ShareEPS-$2.64-$2.19-$1.35-$2.55
 
 
 
 
 
EPS Diluted-$2.64-$2.19-$1.35-$2.55